| Literature DB >> 22849857 |
Abdul Wajid Khan1, Saleem Jan, Shaista Parveen, Rahmat Ali Khan, Asma Saeed, Abdul Jabbar Tanveer, Anwar Ali Shad.
Abstract
BACKGROUND: Aerva javanica (Burm. f.) Juss. ex Schult. (Amaranthacea) is traditionally used for the treatment of wound healings, cough, diarrhoea, ulcer and hyperglycaemia. The current study was aimed to fractionate and isolate bioactive compounds and ultimately to evaluate their anti-ulcereogenic potential.Entities:
Year: 2012 PMID: 22849857 PMCID: PMC3477014 DOI: 10.1186/1752-153X-6-76
Source DB: PubMed Journal: Chem Cent J ISSN: 1752-153X Impact factor: 4.215
Figure 13-hydroxy-4 methoxybenzaldehyde.
H and C NMR spectral data for compound 1
| 1 | 131.6 | - | - |
| 2 | 114.5 | 7.43 | d, |
| 3 | 148.0 | - | - |
| 4 | 153.8 | - | - |
| 5 | 111.9 | 7.12 | d, |
| 6 | 125.1 | 7.34 | dd, |
| OMe | 56.4 | 3.93 | s |
| CHO | - | 9.82 | s |
Figure 2ursolic acid.
H and CNMR spectral data for compound 2
| 1 | 38.5 | 1.56 | m |
| 2 | 27.4 | 1.43 | m |
| 3 | 79.1 | 3.13 | dd, |
| 4 | 38.7 | - | - |
| 5 | 52.4 | 0.66 | s |
| 6 | 18.3 | 1.47 | m |
| 7 | 33.2 | 1.27 | m |
| 8 | 39.6 | - | - |
| 9 | 47.4 | 1.58 | s |
| 10 | 37.1 | - | - |
| 11 | 23.9 | 1.92 | dd, |
| 12 | 125.8 | 5.20 | t, |
| 13 | 138.7 | - | - |
| 14 | 42.0 | - | - |
| 15 | 29.4 | 1.01 | m |
| 16 | 23.5 | 1.53 | m |
| 17 | 47.9 | - | - |
| 18 | 55.2 | 2.20 | d, |
| 19 | 30.5 | 1.31 | m |
| 20 | 30.3 | 1.52 | m |
| 21 | 27.5 | 1.29 | m |
| 22 | 37.0 | 1.54 | m |
| 23 | 24.0 | 1.11 | s |
| 24 | 15.4 | 0.82 | s |
| 25 | 15.9 | 0.97 | s |
| 26 | 17.2 | 0.86 | s |
| 27 | 24.5 | 1.20 | s |
| 28 | 176.2 | - | - |
| 29 | 22.4 | 0.79 | d, |
| 30 | 24.0 | 1.06 | d, |
Figure 3()--(4-hydroxy-3-methoxyphenethyl)-3-(4-hydroxy-3-ethoxyphenyl) acryl amide.
Prominent H and CNMR spectral data for compound 3
| Feruloyl moiety | |||
| 1 | 169.2 | - | - |
| 2 | 118.8 | 5.82 | d, |
| 3 | 142.0 | 6.61 | d, |
| 4 | 132.1 | - | - |
| 5 | 111.6 | 7.36 | d, |
| 6 | 149.9 | - | - |
| 7 | 149.0 | - | - |
| 8 | 116.5 | 6.73 | d, |
| 9 | 123.2 | 6.93 | dd, |
| OMe | 56.4 | 3.82 | s |
| Methoxytyramine moiety | |||
| 1´ | 42.5 | 3.49 | t, |
| 2´ | 36.2 | 2.77 | t, |
| 3´ | 128.3 | - | - |
| 4´ | 113.5 | 6.82 | d, |
| 5´ | 149.3 | - | - |
| 6´ | 146.1 | - | - |
| 7´ | 116.2 | 6.63 | d, |
| 8´ | 122.3 | 6.67 | dd, |
| OMe´ | 56.6 | 3.88 | s |
Effects of various fractions on Urease inhibition
| 1 | 0.2 mg/ml Hexane | 15.3 ± 1.2a |
| 2 | 0.2 mg/ml Dichloromethane | 33.4 ± 3.2b |
| 3 | 0.2 mg/ml Ethyl acetate | 54.6 ± 4.1c |
| 4 | 0.2 mg/ml Water | 5.1 ± 0.9a |
| 5 | 0.2 mg/ml Thiourea | 98.2 ± 5.1d |
Each value (a,b,c and d) in the table is represented as mean ± SD (n = 3).
Effects of isolated compounds 1–3 on Urease inhibition
| 1 | 0.2 mg/ml Compound | 15.3 ± 0.8a |
| 2 | 0.2 mg/ml Compound | 33.4 ± 2.7b |
| 3 | 0.2 mg/ml Compound | 64.6 ± 4.2c |
| 4 | 0.2 mg/ml Thiourea | 98.2 ± 4.3d |
Each value (a,b,c and d) in the table is represented as mean ± SD (n = 3).